Navigation Links
AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007
Date:2/28/2008

Positive cash flow from operations achieved for Q4 and the year

BOSTON, Feb. 28 /PRNewswire-FirstCall/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in radiology and medical image and information management solutions, today reported unaudited financial results for the fourth quarter and year ended December 31, 2007.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

Q4 Financial Highlights

Revenue: Total revenues for the fourth quarter of 2007 were $11.7 million compared to $11.4 million for the fourth quarter of 2006.

Operating Income/Loss: Operating loss for the fourth quarter of 2007 was $1.9 million compared to operating loss of $2.1 million for the fourth quarter of 2006.

Net Income/Loss: The Company's net loss from continuing operations for the fourth quarter of 2007 was $902,000 or $(0.02) per share, compared to net loss from continuing operations of $1.1 million or $(0.03) per share, for the fourth quarter of 2006.

In the fourth quarter of 2007, both operating loss and net loss from continuing operations included a $0.3 million charge related to the elimination of the chief operating officer position, $0.3 million of non-cash stock-based compensation expense, and $0.8 million of depreciation and amortization. In the fourth quarter of 2006, operating loss and net loss from continuing operations included $0.4 million of non-cash stock-based compensation expense and $0.8 million for depreciation and amortization.

Cash and Cash Flow: AMICAS ended the fourth quarter of 2007 with a cash, cash equivalents, and marketable securities balance of $75.6 million, no long- term debt, and work 2007 2006

Operating activities

Loss from continuing operations $(862) $(1,254)

Gain from discontinued operations - 230

Net loss (862) (1,024)

Adjustments to reconcile net income (loss) to cash

used in operating activities:

Gain from the sale of discontinued operations - (230)

Depreciation and amortization 1,119 1,238

Provisions for bad debts, returns and discounts 185 746

Gain on sale of fixed assets - (6)

Amortization of software development costs 1,957 1,958

Non-cash stock compensation expense 1,878 1,763

Changes in operating assets and liabilities:

Accounts receivable 719 3,184

Prepaid expenses and other 1,100 (2,558)

Accounts payable and accrued expenses 1,768 (3,549)

Deferred revenue including unearned discount (889) 2,043

Cash provided by (used in) operating activities 6,975 3,565

Investing activities

Proceeds from sale of assets - 6

Purchases of property and equipment (510) (921)

Purchases of software (2,300) -

Purchases of held-to-maturity securities (94,898) (49,094)

Maturities of held-to-maturity securities 100,263 22,762

Purchases of available-for-sale securities (45,275) (48,405)

Sales of available-for-sale securities 37,340 10,297

Cash (used in) provided by investing activities (5,380) (65,355)

Financing activities

Repurchase of common stock (803) (15,168)

Exercise of stock options and warrants 413 1,632

Tax benefit from change in valuation allow related

to stock option exercises - 443

Cash (used in) provided by financing activities (390) (13,093)

Increase (decrease) in cash and cash equivalents 1,205 (74,883)

Cash and cash equivalents at beginning of year 7,331 82,214

Cash and cash equivalents at end of year $8,536 $7,331

Supplemental disclosure of cash paid during the

period for:

Income taxes, net of refunds $91 $2,425

Non-cash investing activities:

Unrealized gain (loss) on available-for-sale securities $64 $(4)

2008 Projected

Reconciliation of projected net loss to projected Lower Upper

EBITDA Range Range

Projected net loss $(1,350) $(850)

Interest income 3,000 3,000

Operating loss (4,350) (3,850)

Non-cash stock compensation expense 1,816 1,816

Depreciation and amortization 1,286 1,286

Amortization of software development costs 2,286 2,286

Projected EBITDA 1,037 1,537

ing capital of $69.5 million.

Fiscal Year Financial Highlights

Revenue: Total revenues for the year ended December 31, 2007, were $49.9 million compared to $49.4 million for the year ended December 31, 2006.

Operating Income/Loss: Operating loss for the year ended December 31, 2007, was $4.5 million compared to an operating loss of $4.9 million for the year ended December 31, 2006.

Net Income/Loss: The Company's net loss from continuing operations for the year ended December 31, 2007, was $862,000, or $(0.02) per share, compared to a net loss from continuing operations of $1.3 million, or $(0.03) per share, for the year ended December 31, 2006.

For the year ended December 31, 2007, both operating loss and net loss from continuing operations included $1.9 million of stock-based compensation expense and $3.1 million of depreciation and amortization. For the year ended December 31, 2006, both operating loss and net loss from continuing operations included $0.5 million of non-recurring charges, $1.8 million of stock-based compensation expense, and $3.2 million of depreciation and amortization.

Cash Flow: For the year ended December 31, 2007, net cash provided by operations was $7.0 million as compared to net cash provided by operations of $3.6 million for the year ended December 31, 2006.

Stock Repurchase: During the fourth quarter of 2007, the Board of Directors directed the Company to initiate a $25.0 million stock repurchase plan. The Company repurchased approximately 301,000 shares of its common stock for approximately $0.8 million in the last quarter of 2007. Under a previously authorized stock repurchase plan, during 2006, the Company repurchased 4.5 million shares of its common stock for approximately $15.0 million, the total amount authorized by the AMICAS Board of Directors under the prior plan.

Business Perspective

Dr. Stephen Kahane, president, chief executive officer, and chairman of AMICAS, said, "Despite the challenges many companies have felt in this marketplace, AMICAS was able to grow bookings over 20 percent and enter into several very significant new customer partnerships in 2007. Several of the country's largest radiology groups made decisions to use AMICAS products as the basis for their automation infrastructure going forward. Also, one of the largest imaging center enterprises in the country, MedQuest Associates, made the strategic decision to use AMICAS technology as their standard platform for image and information management. In the fourth quarter of 2007, AMICAS was able to sign several very sophisticated and informed imaging service providers. We will work hard to help these new partners succeed and to make sure others follow in their footsteps. It is noteworthy that, despite obstacles such as the Deficit Reduction Act (DRA) and other reimbursement pressures, these groups made the decision to take their automation support to the next level with industry leading offerings from AMICAS."

Dr. Kahane went on to say, "While continuing to invest over 21 percent of our revenues in R&D costs and product enhancement purchases, AMICAS generated positive operating cash flow and ended the year with a strong cash and marketable securities balance, a strong recurring revenue base, and no debt. Everyone at AMICAS worked very hard to improve our operations and to help our customers and partners achieve their goals through the use of our innovative products and services. We believe that AMICAS is entering 2008 in a strong and very competitive position."

"As we have said before, AMICAS remains committed to becoming the leading independent image and information management solutions provider in the healthcare industry. Now more than ever, we believe that our innovative end- to-end suite of products, our strong and experienced team of professionals, and our dedicated focus on image and information management will help our customers and partners by empowering them to grow, differentiate, and efficiently run their practices and businesses in 2008 and beyond."

Dr. Kahane added, "AMICAS has entered 2008 energized, focused, and ready to work relentlessly to reach our goals and objectives and to become the leading independent vendor of choice in the image and information management marketplace."

Looking Forward

AMICAS expects 2008 revenues to be between $52 million and $54 million, with pro-forma EBITDA expected to be between $1.0 million and $1.5 million, which is consistent with a net loss of approximately ($0.02) per share. EBITDA, a non-GAAP financial measure, refers to Net Income, adjusted for Amortization, Depreciation, Interest, and Stock Compensation expense.

A reconciliation of Net Income determined under GAAP to EBITDA is included below. Management believes that its EBITDA measurement, when viewed in addition to the Company's reported GAAP results, provides an additional meaningful measure of operating performance, enabling investors to more thoroughly evaluate current performance in comparison to past performance. This information will necessarily differ from comparable information that may be provided by other companies and should not be considered in isolation or as an alternative to the Company's operating and other financial information determined under GAAP.

Combining a market where imaging businesses continue to embrace automation as part of the response to the DRA with the combination of new product introductions already in progress, AMICAS expects 2008 bookings growth of between 10 to 20 percent. Bookings are defined as contractual commitments from customers for licenses, services, hardware, and maintenance/support.

Conference Call

AMICAS will host a conference call on Friday, February 29, at 8:30 a.m. Eastern Time to discuss the Company's 2007 fourth fiscal quarter and year end results. Investors and other interested parties may dial in to the call using the toll free number 1-800-894-5910. (conference ID: 7AMICAS). The conference call will also be available via Webcast at http://www.amicas.com. Following the conclusion of the call, a replay will be available at 1-800-688-7339 or 402- 220-1347 until March 28, 2008.

AMICAS, Vision Series, Vision Reach, RadStream and AMICAS Insight are trademarks or registered trademarks of AMICAS, Inc.

About AMICAS, Inc.

AMICAS, Inc. (http://www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS(R) Vision Series(TM) products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully integrated, hospital information system-independent PACS that features advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight(TM) Solutions, a set of client-centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.

Safe Harbor Statement

Except for the historical information herein, the matters discussed in this release include forward-looking statements. In particular, the forward- looking statements contained in this release include statements about future financial and operating results. When used in this press release, the words: believes, intends, plans, anticipates, expects, estimates, and similar expressions are intended to identify forward-looking statements. Such forward- looking statements are subject to a number of risks, assumptions and uncertainties that could cause actual results to differ materially which include, but are not limited to, the following: a significant portion of the Company's quarterly sales are concluded in the last month of the fiscal quarter; the length of sales and delivery cycles; the deferral and/or realization of deferred software license and system revenues according to contract terms; the timing, cost and success or failure of current and new product and service introductions and product upgrade releases; potential patent infringement claims against AMICAS and the related defense costs; the ability of AMICAS to comply with all government laws, rules and regulations; and other risks affecting AMICAS' businesses generally and as set forth in AMICAS' most recent filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" of our most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q. All forward- looking statements in this release are qualified by these cautionary statements and are made only as of the date of this release. AMICAS is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise. The financial statements and information as of, and for the period ended, December 31, 2007 contained in this press release are subject to review by the Company's independent registered public accounting firm.

CONTACT: Lisa Gould, Investor Relations

617.779.7892

lgould@amicas.com

Condensed Consolidated Balance Sheets

(in thousands, except share data)

December 31, December 31,

2007 2006

Assets

Current assets:

Cash and cash equivalents $8,536 $7,331

Marketable debt securities 67,071 64,436

Accounts receivable, net of allowances of $231

and $1,050, respectively 10,483 11,387

Prepaid expenses and other current assets 3,600 4,729

Total current assets 89,690 87,883

Property and equipment, less accumulated

depreciation and amortization of $6,848

and $6,155, respectively 1,186 1,369

Goodwill 27,313 27,313

Acquired/developed software, less accumulated

amortization of $7,992 and $6,035, respectively 8,008 7,665

Other intangible assets, less accumulated

amortization of $1,742 and $1,316, respectively 1,658 2,084

Other assets 586 557

Total Assets $128,441 $126,871

Liabilities and stockholders' equity

Current liabilities:

Accounts payable and accrued expenses $9,820 $8,052

Deferred revenue, including unearned

discounts of $0 and $336, respectively 10,375 10,867

Total current liabilities 20,195 18,919

Other liabilities, primarily unearned discounts

re: outsourced printing services - 397

Commitments and contingencies

Stockholders' equity:

Preferred stock $.001 par value; 2,000,000

shares authorized; none issued - -

Common stock $.001 par value, 200,000,000 shares

authorized, 51,296,823 and 51,066,966 issued,

respectively 51 51

Additional paid-in capital 229,056 226,764

Accumulated other comprehensive 60 (4)

income

Accumulated deficit (98,478) (97,616)

Treasury stock, at cost, 6,824,192 and

6,523,392 shares (22,443) (21,640)

Total stockholders' equity 108,246 107,555

Total Liabilities and Stockholders' Equity $128,441 $126,871

Condensed Consolidated Statements Of Operations

(in thousands, except per share data)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Revenues

Maintenance and services $9,645 $8,991 $38,175 $36,258

Software licenses and system sales 2,007 2,453 11,713 13,179

Total revenues 11,652 11,444 49,888 49,437

Costs and expenses

Cost of revenues:

Maintenance and services (a) 4,134 3,898 16,469 15,003

Software licenses and system sales,

including amortization of software

costs of $489, $489, $1,957 and

$1,958, respectively 1,326 1,424 6,486 7,644

Selling, general and administrative (b) 5,662 5,866 21,809 21,770

Research and development (c) 2,115 2,075 8,527 8,705

Depreciation and amortization 284 294 1,120 1,238

13,521 13,557 54,411 54,360

Operating loss (1,869) (2,113) (4,523) (4,923)

Interest income 991 988 3,870 3,753

Loss from continuing operations,

before income taxes (878) (1,125) (653) (1,170)

Provision for income taxes 24 21 209 84

Loss from continuing operations (902) (1,146) (862) (1,254)

Gain on sale of discontinued

operations, net of taxes of $230 - - - 230

Net loss $(902) $(1,146) $(862)$(1,024)

Loss per share

Basic:

Continuing operations $(0.02) $(0.03) $(0.02) $(0.03)

Discontinued operations 0.00 0.00 0.00 0.00

$(0.02) $(0.03) $(0.02) $(0.03)

Diluted:

Continuing operations $(0.02) $(0.03) $(0.02) $(0.03)

Discontinued operations 0.00 0.00 0.00 0.00

$(0.02) $(0.03) $(0.02) $(0.03)

Weighted average number of shares

outstanding:

Basic 44,746 45,135 44,657 46,499

Diluted 44,746 45,135 44,657 46,499

(a) - includes $30,000, $107,000, $17,000 and $54,000 in stock-based

compensation expense for the three and twelve months ended

December 31, 2007 and December 31, 2006, respectively.

(b) - includes $0.2 million, $1.5 million, $0.3 million and $1.5 million

in stock-based compensation expense for the three and twelve months

ended December 31, 2007 and December 31, 2006, respectively

(c) - includes $67,000, $267,000, $55,000 and $196,000 in stock-based

compensation expense for the three and twelve months ended

December 31, 2007 and December 31, 2006, respectively.

CONDENSED Consolidated Statements Of Cash Flows

(in thousands)

Twelve Months

Ended

December 31,


'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call
2. AMICAS to Present at UBS Global Healthcare Services Conference
3. MedQuest Standardizes on AMICAS Vision Series PACS
4. AMICAS Solutions Closing the Loop in Radiology Communications
5. AMICAS Transforms Critical Results Notification with RadStream
6. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
7. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
8. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
9. AMICAS Schedules Third Quarter Earnings Call
10. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
11. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: